Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
J Med Virol ; 94(1): 303-309, 2022 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1544346

RESUMEN

Emerging evidence shows co-infection with atypical bacteria in coronavirus disease 2019 (COVID-19) patients. Respiratory illness caused by atypical bacteria such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila may show overlapping manifestations and imaging features with COVID-19 causing clinical and laboratory diagnostic issues. We conducted a prospective study to identify co-infections with SARS-CoV-2 and atypical bacteria in an Indian tertiary hospital. From June 2020 to January 2021, a total of 194 patients with laboratory-confirmed COVID-19 were also tested for atypical bacterial pathogens. For diagnosing M. pneumoniae, a real-time polymerase chain reaction (PCR) assay and serology (IgM ELISA) were performed. C. pneumoniae diagnosis was made based on IgM serology. L. pneumophila diagnosis was based on PCR or urinary antigen testing. Clinical and epidemiological features of SARS-CoV-2 and atypical bacteria-positive and -negative patient groups were compared. Of the 194 patients admitted with COVID-19, 17 (8.8%) were also diagnosed with M. pneumoniae (n = 10) or C. pneumoniae infection (n = 7). Confusion, headache, and bilateral infiltrate were found more frequently in the SARS CoV-2 and atypical bacteria co-infection group. Patients in the M. pneumoniae or C. pneumoniae co-infection group were more likely to develop ARDS, required ventilatory support, had a longer hospital length of stay, and higher fatality rate compared to patients with only SARS-CoV-2. Our report highlights co-infection with bacteria causing atypical pneumonia should be considered in patients with SARS-CoV-2 depending on the clinical context. Timely identification of co-existing pathogens can provide pathogen-targeted treatment and prevent fatal outcomes of patients infected with SARS-CoV-2 during the current pandemic.


Asunto(s)
Formas Bacterianas Atípicas/aislamiento & purificación , COVID-19/patología , Infecciones por Chlamydophila/epidemiología , Coinfección/epidemiología , Enfermedad de los Legionarios/epidemiología , Neumonía por Mycoplasma/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Chlamydophila pneumoniae/aislamiento & purificación , Femenino , Humanos , India , Legionella pneumophila/aislamiento & purificación , Tiempo de Internación , Masculino , Persona de Mediana Edad , Mycoplasma pneumoniae/aislamiento & purificación , Estudios Prospectivos , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Adulto Joven
3.
Euro Surveill ; 25(30)2020 07.
Artículo en Inglés | MEDLINE | ID: covidwho-690936

RESUMEN

We report a case of Legionella pneumonia in a dishwasher of a restaurant in Rome, Italy, just after the end of the lockdown that was in place to control the SARS-CoV-2 epidemic. The case highlights the importance of strict monitoring of water and air systems immediately before reopening business or public sector buildings, and the need to consider Legionella infections among the differential diagnosis of respiratory infections after lockdown due to the ongoing COVID-19 pandemic.


Asunto(s)
Antígenos Bacterianos/orina , Legionella pneumophila/aislamiento & purificación , Legionella/aislamiento & purificación , Enfermedad de los Legionarios/diagnóstico , Levofloxacino/uso terapéutico , Neumonía/diagnóstico , Administración Intravenosa , Adulto , Antiinfecciosos Urinarios/uso terapéutico , Tos/etiología , Fiebre/etiología , Cefalea/etiología , Humanos , Enfermedad de los Legionarios/tratamiento farmacológico , Enfermedad de los Legionarios/orina , Masculino , Neumonía/tratamiento farmacológico , Neumonía/orina , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA